ANIX

SEC Filing Summary: CopyTele, Inc. (10-Q)

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for CopyTele, Inc. (not Anixa Biosciences Inc.) for the period ended January 31, 1999. The company is classified as a Development Stage Enterprise incorporated in 1982. Its primary business involves the development and marketing of the MAGICOM(R) 2000, a multi-functional telecommunications product utilizing E-Paper(TM) flat panel display technology. The company also operates a 55% owned joint venture in Shanghai, China (SCE), and is developing new products including a digital encryption device ("The Bump") in partnership with Harris Corporation.

Key Financial Metrics

Note: The Joint Venture (SCE) holds short-term loans of approximately $1.12 million secured by land and building assets.

Material Changes vs. Prior Period

• Expense Reduction: Selling, general, and administrative expenses decreased by approximately $543,000 compared to the prior year quarter. This was driven by reduced research and development costs (specifically for flat panel displays), lower engineering supply purchases, and reduced marketing and professional fees.
• Joint Venture Loss: The company's share of the loss from the Shanghai Joint Venture decreased by approximately $68,000 to $68,628, attributed to cost reductions and production efficiencies.
• Interest Income: Interest income dropped significantly from $158,150 to $52,827 due to a decrease in average funds available for investment (from ~$11.4M to ~$4.6M weighted average).
• Inventory Build-up: Inventory increased by approximately $272,000 to nearly $3 million as the company prepared for product distribution.

Outlook, Risks, and Management Commentary

• Liquidity: Management believes current cash resources (~$4.87M in cash and marketable securities) are sufficient to fund operations into the second quarter of fiscal 2000. However, the company may need to raise additional funds via private stock sales to maintain NASDAQ listing requirements ($4M net tangible assets) and fund R&D.
• Revenue Recognition: The company has recorded no sales since inception. Revenue is only recognized when distributors sell products to end-users. Management is reducing product prices to stimulate sales.
• Asset Realizability: There is significant risk regarding the realizability of inventory and amounts due from the Joint Venture ($3.66M). These assets depend entirely on future product sales. If sales do not materialize, further write-downs may be required.
• Year 2000 Compliance: The company estimates Year 2000 remediation costs will not exceed $20,000 and believes its systems and products are compliant, though a contingency plan is being formulated.
• Strategic Partnership: A new agreement with Harris Corporation (dated March 3, 1999) outlines the development of "The Bump," a digital encryption device. The agreement is capped at $50,000 for the initial phase.

Investor Verification Checklist

• Revenue Recognition Policy: Verify the specific criteria for "end-user acceptance" required to recognize revenue, given the company has zero sales to date despite holding nearly $3M in inventory.
• Joint Venture Solvency: Assess the financial health of the Shanghai Joint Venture (SCE) and its ability to repay the $3.66M owed to CopyTele, as this is a major asset on the balance sheet.
• Inventory Valuation: Confirm the net realizable value of the $3M inventory, particularly given the company's admission that it may need to further reduce selling prices to move product.
• Capital Requirements: Monitor the company's ability to maintain the $4M net tangible asset threshold required for NASDAQ listing without dilutive stock offerings.
• Executive Compensation Waivers: Note that the Chairman, President, and senior personnel have waived salaries and benefits; verify if this arrangement is sustainable or if it will reverse, impacting future cash burn.